Search - tctmd.com

Displaying 461 - 480 of 838

Sort: Relevancy | Date

News Daily News

For Better CV Health, Ask About Diet and Propose Change, Says AHA

Caitlin E. Cox

August 12, 2020

News Daily News

ADHD Drug Overprescribing Raises Concerns Over Future CV Events

L.A. McKeown

August 11, 2020

News Daily News

High-Sensitivity Troponin Hones ASCVD Risk in Secondary Prevention

Michael O'Riordan

August 11, 2020

News Daily News

New Guidance on Use of Diabetes Drugs for CVD Risk Reduction: ACC Experts

Michael O'Riordan

August 06, 2020

News Daily News

NSAIDs Boost CV, Bleeding Risks in Post-MI Patients

Todd Neale

July 28, 2020

News Daily News

Race and Gender Bias May Sway Decisions in Advanced HF Care

L.A. McKeown

July 21, 2020

News Daily News

PAD Patients Undertreated With Statins Despite Elevated CV Risk

L.A. McKeown

July 13, 2020

News Daily News

Black Patients in RCTs of PCI Show Worse Long-term Outcomes

Caitlin E. Cox

July 10, 2020

News Daily News

Inflammation Plays Into the ASCVD Risk Associated With Lp(a): ACCELERATE

Michael O'Riordan

July 08, 2020

News Daily News

Myocardial Injury Seen in Over One-Third of Hospitalized COVID-19 Patients

Michael O'Riordan

June 10, 2020

News Daily News

Cardiology Societies Unite to Condemn Racism and Health Inequality

L.A. McKeown

June 01, 2020

News Daily News

US Prescriptions During COVID-19: Hydroxychloroquine Soars, CVD Drugs Stable

Shelley Wood

May 29, 2020

News Daily News

AHA: Increased Diabetes, CVD Risk for American Indians, Alaskan Natives

Yael L. Maxwell

May 29, 2020

News Daily News

US Poverty Drives CVD in Low-Income Adults Beyond Traditional Risk Factors

L.A. McKeown

May 28, 2020

News Daily News

FOURIER Surveys Reassure About Cognitive Safety of Evolocumab

Todd Neale

May 06, 2020

News Daily News

FDA Clears Dapagliflozin for Heart Failure With Reduced Ejection Fraction

Shelley Wood

May 06, 2020

News Daily News

Later CVD Risk From Hypertension in Pregnancy Vastly Underestimated

L.A. McKeown

May 05, 2020

News Daily News

Alirocumab ‘Modestly’ Cost-effective at Lower List Price: ODYSSEY OUTCOMES

Michael O'Riordan

May 04, 2020

News Daily News

Like Tobacco, Long-term E-Cigarettes Harm Vascular Function

Caitlin E. Cox

April 30, 2020

News Daily News

Different Markers of Dyslipidemia Could Help Fine-tune CVD Prevention

Yael L. Maxwell

April 28, 2020

Advertisement

For Better CV Health, Ask About Diet and Propose Change, Says AHA

ADHD Drug Overprescribing Raises Concerns Over Future CV Events

High-Sensitivity Troponin Hones ASCVD Risk in Secondary Prevention

New Guidance on Use of Diabetes Drugs for CVD Risk Reduction: ACC Experts

NSAIDs Boost CV, Bleeding Risks in Post-MI Patients

Race and Gender Bias May Sway Decisions in Advanced HF Care

PAD Patients Undertreated With Statins Despite Elevated CV Risk

Black Patients in RCTs of PCI Show Worse Long-term Outcomes

Inflammation Plays Into the ASCVD Risk Associated With Lp(a): ACCELERATE

Myocardial Injury Seen in Over One-Third of Hospitalized COVID-19 Patients

Cardiology Societies Unite to Condemn Racism and Health Inequality

US Prescriptions During COVID-19: Hydroxychloroquine Soars, CVD Drugs Stable

AHA: Increased Diabetes, CVD Risk for American Indians, Alaskan Natives

US Poverty Drives CVD in Low-Income Adults Beyond Traditional Risk Factors

FOURIER Surveys Reassure About Cognitive Safety of Evolocumab

FDA Clears Dapagliflozin for Heart Failure With Reduced Ejection Fraction

Later CVD Risk From Hypertension in Pregnancy Vastly Underestimated

Alirocumab ‘Modestly’ Cost-effective at Lower List Price: ODYSSEY OUTCOMES

Like Tobacco, Long-term E-Cigarettes Harm Vascular Function

Different Markers of Dyslipidemia Could Help Fine-tune CVD Prevention

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content